Literature DB >> 16165254

Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients.

Daniela Uberti1, Cristina Lanni, Teresina Carsana, Simona Francisconi, Cristina Missale, Marco Racchi, Stefano Govoni, Maurizio Memo.   

Abstract

Here we show that fibroblasts from sporadic Alzheimer's disease (AD) patients specifically express an anomalous and detectable conformational state of p53 that makes these cells distinct from fibroblasts of age-matched non-AD subjects. In particular, we found that, in contrast to non-AD fibroblasts, p53 in AD fibroblasts is expressed at higher levels in resting condition, and presents a significant impairment of its DNA binding and transcriptional activity. All together, these findings figured out the presence of a mutant-like p53 phenotype. However, gene sequencing of the entire p53 gene from either AD or non-AD did not unravel point mutations. Based on immunoprecipitation studies with conformation-specific p53 antibodies (PAb1620 and PAb240), which discriminated folded versus unfolded p53 tertiary structure, we found that a significant amount of p53 assumed an unfolded tertiary structure in fibroblasts from AD patients. This conformational mutant-like p53 form was virtually undetectable in fibroblasts from non-AD patients. These data, independently from their relevance in understanding the etiopathogenesis of AD, might be useful for supporting AD diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16165254     DOI: 10.1016/j.neurobiolaging.2005.06.013

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

1.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Xinglong Wang; Bo Su; Hisashi Fujioka; Xiongwei Zhu
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

2.  The amyloid precursor protein (APP) intracellular domain regulates translation of p44, a short isoform of p53, through an IRES-dependent mechanism.

Authors:  Mi Li; Mariana Pehar; Yan Liu; Anita Bhattacharyya; Su-Chun Zhang; Kenneth J O'Riordan; Corinna Burger; Luciano D'Adamio; Luigi Puglielli
Journal:  Neurobiol Aging       Date:  2015-06-21       Impact factor: 4.673

3.  Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival.

Authors:  Cristina Lanni; Lavinia Nardinocchi; Rosa Puca; Serena Stanga; Daniela Uberti; Maurizio Memo; Stefano Govoni; Gabriella D'Orazi; Marco Racchi
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

Review 4.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

5.  PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients.

Authors:  Milena Damjanac; Guylène Page; Stéphanie Ragot; Guillaume Laborie; Roger Gil; Jacques Hugon; Marc Paccalin
Journal:  J Cell Mol Med       Date:  2009-02-04       Impact factor: 5.295

6.  Biomarkers of Alzheimer's disease: from central nervous system to periphery?

Authors:  Enrico Mossello; Elena Ballini; Anna Maria Mello; Francesca Tarantini; David Simoni; Samuele Baldasseroni; Niccolò Marchionni
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

Review 7.  Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?

Authors:  Serena Stanga; Cristina Lanni; Stefano Govoni; Daniela Uberti; Gabriella D'Orazi; Marco Racchi
Journal:  Aging (Albany NY)       Date:  2010-09       Impact factor: 5.682

8.  Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease.

Authors:  Laura Buizza; Giovanna Cenini; Cristina Lanni; Giulia Ferrari-Toninelli; Chiara Prandelli; Stefano Govoni; Erica Buoso; Marco Racchi; Maria Barcikowska; Maria Styczynska; Aleksandra Szybinska; David Allan Butterfield; Maurizio Memo; Daniela Uberti
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

9.  Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.

Authors:  Carolina Alquezar; Noemí Esteras; Ainhoa Alzualde; Fermín Moreno; Matilde S Ayuso; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  Alzheimer's disease: new diagnostic and therapeutic tools.

Authors:  Marco Racchi; Daniela Uberti; Stefano Govoni; Maurizio Memo; Cristina Lanni; Sonya Vasto; Giuseppina Candore; Calogero Caruso; Loriana Romeo; Giovanni Scapagnini
Journal:  Immun Ageing       Date:  2008-08-13       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.